Skip to main content
    F

    Femasys Inc (FEMY)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $1.28
    -0.14 (-9.86%)

    Market Cap: $11.89M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Femasys Inc (FEMY) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Femasys (FEMY) trades at 5.6x sales and 0.4x book value. Its P/B of 0.4x is below its 5-year median of 2.7x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/EN/A
    Price to sales5.6x
    Price to book0.4x
    EV/FCF0.5x
    PEGN/A
    FCF yield-156.3%
    As of Nov 17, 2026

    Historical Medians

    MultipleCurrent5-year median10-year median
    P/B0.4x2.7xN/A
    Medians of month-end values through Oct 2026: 58 months (5-year).

    Valuation History

    Over the 5 year ends shown, its P/S ranged from 8.8x in 2022 to 443.8x in 2021.

    Year endPriceP/SP/B
    2025$11.529.9x5.2x
    2024$22.0015.0x4.1x
    2023$19.5014.0x1.4x
    2022$18.008.8x0.6x
    2021$78.00443.8x32.1x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About FEMY

    Is FEMY stock overvalued?

    GNG's valuation label for FEMY is Undervalued.

    What is FEMY's price to sales ratio?

    Femasys has a price to sales ratio of 5.6x.